Month: March 2017

Peter B. Budetti spoke to HCCA’s Report on Medicare Compliance in its March 27, 2017 issue about a proposed boost in the FY2018 presidential budget to the Centers for Medicare & Medicaid’s...

Two Phillips & Cohen whistleblower attorneys wrote an article for New York University’s Compliance & Enforcement blog that examines the issue of who is a whistleblower as defined by the Dodd-Frank...

A recent decision by a federal court in California has helped clarify that whistleblowers can still stop harmful off-label marketing by pharma companies through “qui tam” lawsuits in certain instances...

Letter to the Editor by Sean McKessy in the Australian Financial Review, 3/6/2017 “Critics of a legislative proposal to reward whistleblowers as a way to encourage them to come forward are totally...

A recent Appeals Court decision could force whistleblowers into lengthy and expensive litigation, even if a whistleblower and defendant reach a settlement agreement for a “qui tam” (whistleblower)...